阿尔茨海默病(Alzheimer’s disease, AD)是一种进行性的神经退行性疾病,也是最常见的痴呆症。世界上65岁及以上的老年人超过10%患有AD。AD在神经病理学上与特定脑区域中神经元和突触的进行性损失、淀粉样蛋白斑块和神经纤维缠结的沉积...阿尔茨海默病(Alzheimer’s disease, AD)是一种进行性的神经退行性疾病,也是最常见的痴呆症。世界上65岁及以上的老年人超过10%患有AD。AD在神经病理学上与特定脑区域中神经元和突触的进行性损失、淀粉样蛋白斑块和神经纤维缠结的沉积、神经炎症、血脑屏障(Blood-brain barrier, BBB)破坏、线粒体功能障碍及氧化应激相关。尽管做了大量的努力,仍然没有治愈该疾病的方法。近年来,随着科学家们对外泌体进行深入研究,发现神经源性外泌体在治疗包括AD在内的各种疾病方面具有很大的前景,因为它们含有多种抗凋亡、抗炎和抗氧化成分。不仅如此,神经源性外泌体还促进神经发生和血管生成并修复受损的BBB。因此,本文主要概述外泌体的生物发生及吸收、总结神经源性外泌体治疗AD的最新数据及讨论神经源性外泌体治疗AD的挑战和前景。Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the most common form of dementia. More than 10% of the world’s elderly people aged 65 and over have AD. AD is neuropathologically associated with progressive loss of neurons and synapses in specific brain regions, deposition of amyloid plaques and neurofibrillary tangles, neuroinflammation, blood-brain barrier (BBB) disruption, mitochondrial dysfunction, and oxidative stress. Despite a lot of efforts, there is still no cure for the disease. In recent years, as scientists have conducted in-depth research on exosomes, it has been found that neurogenic exosomes have great promise in the treatment of various diseases, including AD, because they contain a variety of anti-apoptotic, anti-inflammatory, and antioxidant components. Not only that, neurogenic exosomes also promote neurogenesis and angiogenesis and repair damaged BBBs. Therefore, this article mainly summarizes the biogenesis and absorption of exosomes, summarizes the latest data of neurogenic exosomes in the treatment of AD, and discusses the challenges and prospects of neurogenic exosomes in the treatment of AD.展开更多
目的评价椎旁联合腰丛-坐骨神经阻滞在高龄肥胖患者髋关节置换术中的应用价值。方法髋关节置换手术的肥胖高龄患者57例,随机分为椎旁联合腰丛-坐骨神经阻滞组(A组)与腰丛-坐骨神经阻滞组(B组),记录2组手术前,切皮时,手术开始后10、15、2...目的评价椎旁联合腰丛-坐骨神经阻滞在高龄肥胖患者髋关节置换术中的应用价值。方法髋关节置换手术的肥胖高龄患者57例,随机分为椎旁联合腰丛-坐骨神经阻滞组(A组)与腰丛-坐骨神经阻滞组(B组),记录2组手术前,切皮时,手术开始后10、15、20、25、30 min患者收缩压、舒张压及心率变化,并在各时间点对其进行感觉运动功能评分。结果切皮时A组的血流动力学稳定(P<0.05)。阻滞后10、15、20 min A组的感觉评分≤2分的比例较高(P<0.05)。结论椎旁阻滞联合腰丛-坐骨神经阻滞组用于肥胖高龄患者髓关节置换术起效快、镇痛完全、肌松充分,值得临床推广应用。展开更多
文摘阿尔茨海默病(Alzheimer’s disease, AD)是一种进行性的神经退行性疾病,也是最常见的痴呆症。世界上65岁及以上的老年人超过10%患有AD。AD在神经病理学上与特定脑区域中神经元和突触的进行性损失、淀粉样蛋白斑块和神经纤维缠结的沉积、神经炎症、血脑屏障(Blood-brain barrier, BBB)破坏、线粒体功能障碍及氧化应激相关。尽管做了大量的努力,仍然没有治愈该疾病的方法。近年来,随着科学家们对外泌体进行深入研究,发现神经源性外泌体在治疗包括AD在内的各种疾病方面具有很大的前景,因为它们含有多种抗凋亡、抗炎和抗氧化成分。不仅如此,神经源性外泌体还促进神经发生和血管生成并修复受损的BBB。因此,本文主要概述外泌体的生物发生及吸收、总结神经源性外泌体治疗AD的最新数据及讨论神经源性外泌体治疗AD的挑战和前景。Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the most common form of dementia. More than 10% of the world’s elderly people aged 65 and over have AD. AD is neuropathologically associated with progressive loss of neurons and synapses in specific brain regions, deposition of amyloid plaques and neurofibrillary tangles, neuroinflammation, blood-brain barrier (BBB) disruption, mitochondrial dysfunction, and oxidative stress. Despite a lot of efforts, there is still no cure for the disease. In recent years, as scientists have conducted in-depth research on exosomes, it has been found that neurogenic exosomes have great promise in the treatment of various diseases, including AD, because they contain a variety of anti-apoptotic, anti-inflammatory, and antioxidant components. Not only that, neurogenic exosomes also promote neurogenesis and angiogenesis and repair damaged BBBs. Therefore, this article mainly summarizes the biogenesis and absorption of exosomes, summarizes the latest data of neurogenic exosomes in the treatment of AD, and discusses the challenges and prospects of neurogenic exosomes in the treatment of AD.
文摘目的评价椎旁联合腰丛-坐骨神经阻滞在高龄肥胖患者髋关节置换术中的应用价值。方法髋关节置换手术的肥胖高龄患者57例,随机分为椎旁联合腰丛-坐骨神经阻滞组(A组)与腰丛-坐骨神经阻滞组(B组),记录2组手术前,切皮时,手术开始后10、15、20、25、30 min患者收缩压、舒张压及心率变化,并在各时间点对其进行感觉运动功能评分。结果切皮时A组的血流动力学稳定(P<0.05)。阻滞后10、15、20 min A组的感觉评分≤2分的比例较高(P<0.05)。结论椎旁阻滞联合腰丛-坐骨神经阻滞组用于肥胖高龄患者髓关节置换术起效快、镇痛完全、肌松充分,值得临床推广应用。
